In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Pitney Bowes trades at a 53% premium to its high-confidence fair value estimate of $8.09, indicating potential overvaluation. Financial health scores reveal weak profitability and liquidity despite strong leverage, while Monte Carlo analysis shows a 97.2% downside risk below current price, emphasizing high investment volatility and risk.